Table: Garna Biosciences -2020 group results

Carna Biosciences

12/02/2021 06:30

Feb 12 (Reuters)- 
          Garna Biosciences Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended        Year to         NEXT   
                Dec 31, 2020    Dec 31, 2019     Dec 31, 2021      YEAR     
                   LATEST         YEAR-AGO         COMPANY        COMPANY   
                   RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales             1.13            3.21           923 mln                  
                 (-64.7 pct)    (+325.0 pct)     (-18.5 pct)                
  Operating       loss 1.06        977 mln        loss 1.81                 
  Recurring       loss 1.08        957 mln        loss 1.82                 
  Net
  Net             loss 1.11        828 mln        loss 1.83                 
  EPS          loss 90.33 yen     76.05 yen    loss 147.19 yen              
  EPS Diluted                     74.51 yen                                 
  Ann Div            NIL             NIL             NIL                    
  -Q2 Div            NIL             NIL             NIL                    
  -Q4 Div            NIL             NIL             NIL                    
  
  NOTE - Garna Biosciences Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T